EchoIQ (ASX:EIQ)
ASX announcement history & article coverage
Transparent by design.
Announcments by EchoIQ (ASX:EIQ) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Quarterly Activities Report & Appendix 4C Cashflow Report
Echo IQ reports strong EchoSolv growth, A$107.8m cash and FDA appeal progress
Notice of Annual General Meeting/Proxy Form
Notification of cessation of securities - EIQ
EchoSolv HF FDA 510(k) update
Echo IQ appeal of FDA EchoSolv HF decision accepted
Date of AGM and Closing Date for Director Nominations
EchoSolv HF FDA application update
Echo IQ outlines pathways to pursue FDA clearance for EchoSolv HF after NSE determination
Notification regarding unquoted securities - EIQ
Cleansing Notice
Application for quotation of securities - EIQ
Investor Webinar
EchoSolv HF FDA Application Update
Trading Halt
Pause in Trading
Notification of cessation of securities - EIQ
Proposed issue of securities - EIQ
Initial Director's Interest Notice - Scott Wilkin
Global healthcare investment leader appointed to Board
Appendix 4G and Corporate Governance Statement
Annual Report to Shareholders
Echo IQ advances US commercialisation of EchoSolv platform, FDA review underway for heart failure product, raises A$110m
Preliminary Final Report
Echo IQ reports 40% higher loss and 8.9% revenue decline for FY2026
Cleansing Notice
Application for quotation of securities - EIQ
Convertible note executed with Pro Medicus
Cleansing Notice
Application for quotation of securities - EIQ
Investor Webinar
Quarterly Activities Report & Appendix 4C Cashflow Report
Echo IQ secures $20m Pro Medicus partnership, raises $110m to accelerate US AI cardiovascular expansion
